212 related articles for article (PubMed ID: 27403785)
1. Brivaracetam (Briviact) for epilepsy.
Med Lett Drugs Ther; 2016 Jul; 58(1499):95-6. PubMed ID: 27403785
[No Abstract] [Full Text] [Related]
2. Spritam--a new formulation of levetiracetam for epilepsy.
Med Lett Drugs Ther; 2016 Jun; 58(1497):78-9. PubMed ID: 27305068
[No Abstract] [Full Text] [Related]
3. Brivaracetam in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus.
Strzelczyk A; Klein KM; Willems LM; Rosenow F; Bauer S
Expert Rev Clin Pharmacol; 2016; 9(5):637-45. PubMed ID: 26891946
[TBL] [Abstract][Full Text] [Related]
4. Brivaracetam: An Adjunctive Treatment for Partial-Onset Seizures.
Kappes JA; Hayes WJ; Strain JD; Farver DK
J Clin Pharmacol; 2017 Jul; 57(7):811-817. PubMed ID: 28394442
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of brivaracetam: a new drug to treat epilepsy.
Milovanović JR; Janković SM; Pejčić A; Milosavljević M; Opančina V; Radonjić V; Protrka Z; Kostić M
Expert Opin Pharmacother; 2017 Sep; 18(13):1381-1389. PubMed ID: 28737479
[TBL] [Abstract][Full Text] [Related]
6. Significance of the EEG and epileptiform abnormalities in antiepileptic drug discontinuance.
Britton JW
J Clin Neurophysiol; 2010 Aug; 27(4):249-54. PubMed ID: 20634713
[TBL] [Abstract][Full Text] [Related]
7. Brivaracetam: First Global Approval.
Markham A
Drugs; 2016 Mar; 76(4):517-22. PubMed ID: 26899665
[TBL] [Abstract][Full Text] [Related]
8. Brivaracetam for epilepsy.
Hellerslia V; Asistido JM; Iyamu A
JAAPA; 2019 May; 32(5):21-22. PubMed ID: 31033711
[TBL] [Abstract][Full Text] [Related]
9. Brivaracetam: new compound approved for the treatment of epilepsy.
Zaccara G
Drugs Today (Barc); 2016 Apr; 52(4):219-27. PubMed ID: 27252986
[TBL] [Abstract][Full Text] [Related]
10. Effect of brivaracetam on the anger levels of epilepsy patients. A prospective open-labelled controlled study.
Toledo M; Abraira L; Mazuela G; Quintana M; Cazorla S; Santamarina E
Seizure; 2019 Jul; 69():198-203. PubMed ID: 31079028
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial.
Kwan P; Trinka E; Van Paesschen W; Rektor I; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):38-46. PubMed ID: 24116853
[TBL] [Abstract][Full Text] [Related]
12. Results in the treatment of epilepsy with Morfolep. The effects of Morfolep on partial seizures and generalized convulsive seizures.
Volanschi D; Florescu D; Tudor S
Rev Roum Neurol; 1971; 8(5):361-89. PubMed ID: 5140610
[No Abstract] [Full Text] [Related]
13. Kidney Disease and Epilepsy.
Sazgar M
J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105651. PubMed ID: 33581988
[TBL] [Abstract][Full Text] [Related]
14. Cannabidiol (Epidiolex) for epilepsy.
Med Lett Drugs Ther; 2018 Nov; 60(1559):182-184. PubMed ID: 30681657
[No Abstract] [Full Text] [Related]
15. Brivaracetam for the treatment of epilepsy.
Schulze-Bonhage A
Expert Opin Pharmacother; 2011 Aug; 12(12):1959-66. PubMed ID: 21682662
[TBL] [Abstract][Full Text] [Related]
16. Brivaracetam: a new drug in development for epilepsy and neuropathic pain.
Malawska B; Kulig K
Expert Opin Investig Drugs; 2008 Mar; 17(3):361-9. PubMed ID: 18321235
[TBL] [Abstract][Full Text] [Related]
17. Prediction of potential positive drug interactions.
Nemire RE; Wauquier A
Epilepsy Res Suppl; 1996; 11():245-52. PubMed ID: 9294742
[No Abstract] [Full Text] [Related]
18. The effect of structural white matter abnormalities on the clinical course of epilepsy.
Evstigneev VV; Kistsen VV; Bulaev IV; Sakovich RA
Adv Clin Exp Med; 2013; 22(4):529-37. PubMed ID: 23986213
[TBL] [Abstract][Full Text] [Related]
19. Tritium-labeled brivaracetam with high specific activity: preparation, characterization and application in human brain samples.
Hildenbrand S; Schoch S; von Lehe M; Surges R; Müller CE
ChemMedChem; 2012 Aug; 7(8):1369-74. PubMed ID: 22740425
[No Abstract] [Full Text] [Related]
20. Drugs for epilepsy.
Treat Guidel Med Lett; 2013 Feb; 11(126):9-18. PubMed ID: 23348233
[No Abstract] [Full Text] [Related]
[Next] [New Search]
